Clinical Trial Update: A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase II clinical trial update evaluating the safety and efficacy of interferon-gamma in patients with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: Huntington Medical Research Institutes | Conditions: Hepatitis B | Phase 2 | Status: UNKNOWN